Pulmonary Hypertension (PH) is a progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to right heart failure and significant morbidity and mortality. Hemolytic Anemia (HA), a group of disorders characterized by premature destruction of red blood cells, has been increasingly recognized as a potential cause or contributor to pulmonary hypertension. This mini-review explores the pathophysiological mechanisms linking hemolytic anemia to pulmonary hypertension, clinical presentations, diagnostic challenges, management strategies, and outcomes based on current literature and clinical insights.
HTML PDFShare this article
Journal of Coronary Heart Diseases received 15 citations as per Google Scholar report
